Forian Inc.

Forian Inc.(FORA)股票分析

$2.170

+0.010 (+0.46%)收盘时

Loading chart…
High
2.180
Open
2.160
VWAP
2.17
Vol
87.93K
Mkt Cap
80.96M
Low
2.160
Amount
190.80K
EV/EBITDA, TTM
0.00

Forian Inc. is a healthtech company. It is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. It provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers within the healthcare and life sciences and financial services industries. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its solutions include CHRONOS, Chartis, real-world evidence (RWE) and Kyber Data Science. CHRONOS combines open and closed claims, electronic health records, and social determinants of health data into a single, integrated model. It also provides researchers access to healthcare payers, providers, and clinical data with non-traditional healthcare sources, such as social determinants of health (SDoH) data, to uncover novel insights.

forian.com

估值指标

The current forward P/E ratio for Forian Inc. (FORA) is 23.87, compared to its 5-year average forward P/E of -11.25.

Forward P/E

Overvalued
5Y Average P/E
-11.25
Current P/E
23.87
高估
13.84
低估
-36.33

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
75.41
Current EV/EBITDA
0.00
高估
186.88
低估
-36.07

Forward P/S

Undervalued
5Y Average P/S
3.61
Current P/S
0.00
高估
5.47
低估
1.74

Alphio AI Price Scenarios for FORA

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%FORA

$2.71

情景价格

B

Base

Base · 50%FORA

$2.35

情景价格

B

Bear

Bear · 25%FORA

$2.28

情景价格

Whales holding FORA

S

Staley Capital Advisers, Inc.

+ HoldingFORA

+1.21%

3M Return

FORA FAQ — answered by Alphio AI

Forian Inc. is a healthtech company. It is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. It provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers within the healthcare and life sciences and financial services industries. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its solutions include CHRONOS, Chartis, real-world evidence (RWE) and Kyber Data Science. CHRONOS combines open and closed claims, electronic health records, and social determinants of health data into a single, integrated model. It also provides researchers access to healthcare payers, providers, and clinical data with non-traditional healthcare sources, such as social determinants of health (SDoH) data, to uncover novel insights. It operates in the Healthcare sector (SERVICES-COMPUTER PROCESSING & DATA PREPARATION industry).

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始